|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||108.40 - 109.78|
|52 Week Range||95.20 - 123.55|
|PE Ratio (TTM)||24.18|
|Earnings Date||Apr 19, 2018|
|Forward Dividend & Yield||4.28 (3.93%)|
|1y Target Est||122.53|
Philip Morris (PM) continues to benefit from reduced risk products expansion efforts. However, declining cigarette consumption is a woe.
On January 19, 2018, Jefferies upgraded Philip Morris International (PM) from “hold” to “buy” and raised its 12-month target price to $124. The new target price represents a return potential of 13.8% from its current stock price of $108.92. Owen Bennett of Jeffries expects the Tobacco Products Scientific Advisory Committee’s review of Philip Morris’s iQOS system, which is expected to be announced this week, to drive Philip Morris’s stock price.
In a decision expected to test the Trump administration's approach to tobacco regulation, U.S. health advisers will vote this week on whether to allow Philip Morris International Inc (PM.N) to claim its novel iQOS tobacco device is less harmful than cigarettes. IQOS is designed to heat tobacco but not burn it, and comes in a sleek package that would not look out of place in an Apple store. Most of the harmful chemicals in tobacco are released when tobacco is burned, forming the basis of Philip Morris's claim of a less-risky product.
WASHINGTON (AP) — A device that heats tobacco without burning it reduces some of the harmful chemicals in traditional cigarettes, but government scientists say it's unclear if that translates into lower rates of disease for smokers who switch.
An electronic product made by Philip Morris International Inc that heats rather than burns tobacco contains lower levels of harmful and potentially harmful compounds than cigarettes, a preliminary review by the U.S. Food and Drug Administration (FDA) concluded on Monday. Laboratory data showed that the aerosol produced by the product, iQOS, can damage cells and affect human tissue, but that the effects "are generally less severe and observed at much higher concentrations," compared to cigarette smoke. The reviewers said full results from a pending study would provide more information about the carcinogenic potential of iQOS, but the results are not expected to become available until later this year.
Philip Morris International Inc. wants to shift to a “smoke-free future,” but U.S. regulators are concerned that they will need more data to fully assess potential health risks from the company’s new electronic ...
On January 19, 2018, Jefferies upgraded Altria Group (MO) from “hold” to “buy,” and raised its target price from $72 to $81. The new price target represents a return potential of 13.9% based on its current stock price of $71.12. Jefferies analyst Owen Bennett is optimistic on tobacco companies, based on them having a lower valuation than other staples.
NEW YORK, NY / ACCESSWIRE / January 22, 2018 / U.S. markets rebounded on Friday, posting a weekly gain, as positive earnings outweighed worries of a government shutdown. The Dow Jones Industrial Average ...
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Philip Morris International Inc.
NEW YORK, Jan. 20, 2018-- Pomerantz LLP announces that a class action lawsuit has been filed against Philip Morris International Inc. and certain of its officers. The class action, filed in United States ...
Shares of Philip Morris International (PM) and Altria Group (MO) are higher on Friday, thanks to an upgrade from Jefferies. Analyst Owen Bennett and his team boosted their rating on Philip Morris and Altria to Buy from Hold, writing that they're bullish on the tobacco sector in 2018, given the stocks' discounts to other staples and their reasonable valuations. As for specific stock catalysts, Bennett writes that Philip Morris should benefit from the Tobacco Products Scientific Advisory Committee's review of its iQOS system expected next week, which could help it gain ground after recent pressures. At Altria, he writes that the focus will be on whether it can halt share declines at its Marlboro brand. Bennett also upgraded Japan Tobacco (JAPAY) to Hold from Sell, although he's still concerned that earnings expectations are too high for the stock.
WASHINGTON (AP) — Imagine if cigarettes were no longer addictive and smoking itself became almost obsolete; only a tiny segment of Americans still lit up. That's the goal of an unprecedented anti-smoking plan being carefully fashioned by U.S. health officials.
NEW YORK, NY / ACCESSWIRE / January 18, 2018 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Philip Morris International Inc. ("Philip Morris" ...
NEW YORK, NY / ACCESSWIRE / January 17, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Philip Morris International Inc. (“Philip Morris” or the “Company”) (NYSE: PM) ...
NEW YORK, NY / ACCESSWIRE / January 13, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Philip Morris International Inc. ("Philip Morris" or the "Company") ...
NEW YORK, Jan. 12, 2018-- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Philip Morris International Inc. ...
NEW YORK, NY / ACCESSWIRE / January 12, 2018 / Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Philip Morris International Inc. (NYSE: ...